MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.thromres.2026.109870

Медицинская библиотека · Thrombosis research · 2026

Complement activation characterizes a high mortality subgroup in pulmonary embolism: An observational proteomic study.

Tenhunen Annelie Barrueta, Eriksson Oskar, Nilsson Bo, Mazubane Asanda, Hawez Kazal, Lipcsey Miklos, Larsson Anders, Åberg Mikael, Wikström Gerhard, Marks-Hultström Michael

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Complement and coagulation pathways are mechanistically linked in thromboinflammation, yet the contribution of complement activation to pulmonary embolism (PE) pathophysiology and risk stratification remains largely unexplored. We used plasma proteomics and functional assays to identify thromboinflammatory endotypes in patients with suspected PE.

METHODS

We enrolled 196 patients referred for CT pulmonary angiography at Uppsala University Hospital (2019-2022). Plasma was analyzed using the Olink Explore 384 Inflammation II panel. Differentially expressed proteins (PE vs no-PE) were used for supervised feature selection, followed by unsupervised clustering to define diagnostic clusters in all patients and prognostic endotypes in confirmed PE cases. Complement and coagulation activation were validated using functional assays.

RESULTS

Eighty-nine patients (45%) had confirmed PE. Twenty-one proteins differed between PE and non-PE (FDR < 0.05), including complement C9 (log2FC 0.53, FDR 2.7 × 10-5), associated with increased soluble C5b-9 (sC5b-9) supporting terminal complement activation. Three diagnostic clusters were identified; the PE-enriched cluster showed higher mortality and evidence of complement and coagulation activation (increased sC5b-9 and thrombin-antithrombin complexes), with intermediate native complement protein levels consistent with consumption. Among confirmed PE cases, three prognostic endotypes emerged, including a high-mortality cluster (50% one-year mortality) with reduced complement protein levels, without parallel increase in functional activation markers.

CONCLUSIONS

Targeted proteomic profiling identified elevated terminal complement C9 in PE, and evidence of complement and coagulation activation, alongside reduced native complement levels. Complement protein levels were also reduced in the high-mortality prognostic endotype. These findings support proteomic endotyping as a biologically informative approach to PE risk stratification.

Для цитирования: Tenhunen Annelie Barrueta, Eriksson Oskar, Nilsson Bo, Mazubane Asanda, Hawez Kazal, Lipcsey Miklos, Larsson Anders, Åberg Mikael, Wikström Gerhard, Marks-Hultström Michael. Complement activation characterizes a high mortality subgroup in pulmonary embolism: An observational proteomic study.. Thrombosis research. 2026. DOI: 10.1016/j.thromres.2026.109870.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.